Differential Effects of Dimethyl Fumarate and Monomethyl Fumarate on Neutrophil Granulocyte and PBMC Apoptosis
- 6 August 2020
- journal article
- letter
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 141 (3), 699-702.e1
- https://doi.org/10.1016/j.jid.2020.06.028
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft
This publication has 25 references indexed in Scilit:
- Neue Erkenntnisse zu Fumarsäureestern (Fumaderm®): Ergebnisse des 2. Experten‐WorkshopsJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2012
- Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cellsThe Journal of Experimental Medicine, 2011
- PsoriasisThe New England Journal of Medicine, 2009
- The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonistBiochemical and Biophysical Research Communications, 2008
- The dual effects of TNFα on neutrophil apoptosis are mediated via differential effects on expression of Mcl-1 and Bfl-1Blood, 2008
- TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative diseaseJournal of Neuroinflammation, 2008
- Neutrophil apoptosis mediated by nicotinic acid receptors (GPR109A)Cell Death & Differentiation, 2007
- Calcium, leukocyte cell death and the use of annexin V: fatal encountersApoptosis, 2007
- Analysis of apoptosis by propidium iodide staining and flow cytometryNature Protocols, 2006
- Dimethylfumarate Is a Potent Inducer of Apoptosis in Human T CellsJournal of Investigative Dermatology, 2003